Fatal leptospirosis presenting as musculoskeletal pain [4]

Medical Journal of Australia

Volumn 181, Issue 4, 2004, Pages 229-

  Morgan, Lloyd K ^a  

^a NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN G; PLACEBO; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; CLINICAL TRIAL; DRUG EFFICACY; EARLY DIAGNOSIS; HERXHEIMER REACTION; HUMAN; IN VITRO STUDY; LEPTOSPIRA; LEPTOSPIROSIS; LETTER; MYALGIA; PRACTICE GUIDELINE; VASCULITIS;

EID: 4444307340     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb06248.x     Document Type: Letter

References (7)

1. O'Leary F, Hanson J, Bradbury R, Thanakrishman G. Fatal leptospirosis presenting as musculoskeletal chest pain. Med J Aust 2004; 180: 29-31.
2. Guidugli F, Castro AA, Atallah AN. Antibiotics for leptospirosis (Cochrane review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
3. Takfuji E, Kirkpatrick J, Miller R, et al. An efficiency trial of doxycyline chemoprophylaxis against leptospirosis. N Engl J Med 1984; 310: 497-500.
4. Kucers A, Crow S, Grayson M, Hoy J. The use of antibiotics: a clinical review of antibacterial, antifungal and antiviral drugs. 5th ed. Boston: Butterworth-Heinemann, 1997.
5. Friedland J, Warral D. The Jarisch-Herxheimer reaction in leptospirosis: possible pathogenesis and review. Rev Infect Dis 1991; 13: 207-210.
6. Katz A, Ansdell V, Effler P, et al. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii 1974-1998. Clin Infect Dis 2001; 33: 1834-1841.
7. Therapeutic guidelines. Antibiotic. Version 12. Melbourne: Therapeutic Guidelines, 2003.